CD274 and breast cancer: Findings by Kamiya et al. (2019) in chemically induced and xenograft models of breast cancer demonstrated that presynaptic cholinergic neurostimulation resulted in decreased immune checkpoint molecules (PD-1 and PD-L1) expression and attenuated tumor growth [51].